INJURY | PERSONAL INJURY LAWYER | PERSONAL INJURY ATTORNEY | INJURIES |
SITE MAP |
|
Jan. 3, 2008—The FDA announced that it is reviewing data from anemia drugs that have been linked to rapid tumor growth and shortened survival time in patients with certain types of cancer. The anemia drugs, called erythropoiesis-stimulating agents, or ESAs, affect patients with certain types of cancer, including:
Common ESAs have the market names Aranesp, Epogen and Procrit. For the time begin, there are very few, and in some cases, no alternatives to ESAs for anemic patients. Patients should discuss the risks with their healthcare providers before using ESAs. Patients using ESAs are also at risk for blood clots, strokes, heart failure and heart attacks, especially patients with kidney disease. Divorce Solicitors in Leeds Maryland Adoption information 410-486-1800 - Aggressive maryland adoption lawyer. Pearland attorney James Zier of Brazoria County practices family law, criminal law and personal injury law. Contact him today to discuss how best to achieve the results you desire and expeditiously resolve your legal issues. Mary E. Ramos is an experienced Houston Divorce Lawyer committed to the practice of Texas family law, adoption, child support, child custody and divorce mediation. Email This Post
Tags: anemia, blood clots, heart attacks, heart failure, strokes Related Posts: 16-Pound Tumor Threatens Girl’s Life Generic Drugs Are Not As Effective, Some Say California to Track Prescription Drugs Do you need legal assistance? If you think you may need the assistance of an attorney please fill out our contact form. |
Categories
ArchivesLinks |
| © 2008 Injury.com
|
Leave a reply